MaryElizabethPattiMDFACP

Diabetes, Lipid Metabolism

Investigator and Adult Endocrinologist, Joslin Diabetes Center and Associate Professor, Harvard Medical School

Dr. Patti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Joslin Pl
# Joslin
Boston, MA 02215
Phone+1 617-735-1966

Fax+1 617-309-2593

Dr. Patti is a physician-scientist, serving as Principal Investigator at Joslin Diabetes Center, Director of the Hypoglycemia Clinic, Co-Director of the Molecular Phenotyping Core, and Associate Professor of Medicine at Harvard Medical School. Dr. Patti’s NIH-funded lab focuses on identification of molecular/epigenetic mechanisms by which nutritional exposures during early life increase diabetes risk in subsequent generations. Translational studies are focused on mechanisms contributing to diabetes resolution and hypoglycemia after bariatric surgery. Dr. Patti received her MD from Jefferson Medical College magna cum laude, with internal medicine residency at University of Pittsburgh, and endocrinology fellowship at Harvard.

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1992 - 1995
UPMC Medical EducationResidency, Internal Medicine, 1985 - 1988
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1985

Fellow American College of Physicians, 2014
Fellow Obesity Society, 2013
CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2012
Diabetes Recognition Program National Committee for Quality Assurance, 2010-2013
Elected Member The American Society for Clinical Investigation, 2009
Join now to see all

PubMed

34 citations
Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring.
Yao Wu, Farshad Tehrani, Hazhir Teymourian, John Mack, Alexander Shaver
Analytical Chemistry. 2022-06-14
793 citations
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.
Kenneth Cusi, Katsumi Maezono, Abdullah A. Osman, Merri Pendergrass, Mary-Elizabeth Patti
The Journal of Clinical Investigation. 2000-02-01
445 citations
Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
Mary-Elizabeth Patti, Sander M. Houten, Antonio C. Bianco, Raquel Bernier, P. Reed Larsen
Obesity. 2009-09-01

Lectures

Evaluation and Treatment of Post-Bariatric Surgery Hypoglycemia
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
Bariatric Surgery: Remodeling the Next Generation
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/17/2018
American Diabetes Association (ADA) 73rd Scientific Sessions 2013
American Diabetes Association, Chicago, Illinois - 6/21/2013

Continuous Glucose Monitoring Might Help in Managing Postoperative HypoglycemiaJuly 28th, 2023
Glucagon Delivery System Treats Post-Bariatric HypoglycemiaJanuary 30th, 2020
New Closed-Loop System Offers Promise as Novel Treatment for Post-Bariatric HypoglycemiaJanuary 9th, 2020
Join now to see all

Genomics CoreNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Gene Expression In Prediabetes: Potential Role Of PGC-1National Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
Core--GenomicsNational Institute Of Diabetes And Digestive And Kidney Diseases2002
Mechanisms Of Ffa-Induced Hepatic Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2001
Bifunctional Modulation Of Insulin Action By Amino AcidsNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001